Sort
130,381 grants matching “hiv”
The Florida Node Alliance of the National Drug Abuse Treatment Clinical Trials Network
$6,601,693Jose Szapocznik · University Of Miami School Of Medicine · UG1 · FY2023 · DA
CFAR Network of Integrated Clinical Systems (CNICS)
$6,592,862Michael S. Saag · University Of Alabama At Birmingham · R24 · FY2021 · AI
Laboratory Center, AIDS Clinical Trials Group (ACTG); LC 2 / 3
$6,586,951Grace M. Aldrovandi · Brigham And Women'S Hospital · UM1 · FY2018 · AI
GH11-1193: STRENGTHENING INTEGRATED HIV AND CHOLERA CARE,
$6,584,925Joia S Mukherjee · Partners In Health · U2G · FY2014 · GH
HIV CARE, SUPPORT & TREATMENT: IMPLEMENTATION OF PROGRAM FOR THE CARE OF HIV/AIDS
$6,579,680Joseph Essombo · Elizabeth Glaser Pediatric Aids Fdn · U2G · FY2016 · GH
Development of Improved DNA Vaccines and Electroporation Delivery Devices for HIV
$6,573,776Niranjan Sardesai · Viral Genomix, Inc. · N01 · FY2009 · AI
PS12-1201 COMPREHENSIVE HIV PREVENTION PROJECT FOR HEALTH DEPTS
$6,572,699Deann Gruber · Louisiana State Office Of Public Health · U62 · FY2012 · PS
Consortium for AIDS Vaccine Research in Nonhuman Primates
$6,572,396Dan H. Barouch · Beth Israel Deaconess Medical Center · U19 · FY2013 · AI
UCSF-GVI Center for AIDS Research
$6,568,894Paul A Volberding · University Of California, San Francisco · P30 · FY2014 · AI
1/2 REPRIEVE Extension for Trial Completion
$6,567,877Steven Kyle Grinspoon · Massachusetts General Hospital · UG3 · FY2023 · HL
VETERINARY/ANIMAL CARE SERVICES
$6,557,277D. Rick Lee · Charles River Laboratories Intntl, Inc. · N02 · FY2010 · RR
HIV PREVENTION TRIALS NETWORK LEADERSHIP GROUP
$6,557,073Family Health International · U01 · FY2005 · AI
CoVPN 3002 A Phase III Randomized, Double-blind, Placebo-controlled Multicenter Study in Adults to Determine the Safety, Efficacy, and Immunogenicity of AZD1222 for the Prevention of COVID-19 LAB
$6,554,653Margaret Juliana McElrath · Fred Hutchinson Cancer Research Center · UM1 · FY2020 · AI
HIV PREVENTION TRIAL UNIT
$6,551,905University Of Pennsylvania · U01 · FY2005 · AI
PS04-012, HIV PREVENTION PROJECTS
$6,548,152Loretta Davis-Satteria · Michigan State Dept Of Public Health · U62 · FY2009 · PS
CAPACITY BUILDING TO SUPPORT LOCAL AND INDIGENOUS ORGS. PROVIDING HIV P&C
$6,545,000Debra J Millar · Global Communities · U62 · FY2006 · PS
SUPPORTING THE IMPLEMENTATION AND EXPANSION OF HIGH QUALITY HIV
$6,543,458Craig R Cohen · University Of California, San Francisco · U2G · FY2011 · PS
PS12-1201 COMPREHENSIVE HIV PREVENTION PROJECT FOR HEALTH DEPTS
$6,535,091Marlene McNeese-Ward · Houston Department/Health/Human Srvs · U62 · FY2015 · PS
Pediatric Adolescent Virus Elimination (PAVE) Martin Delaney Collaboratory
$6,531,642Deborah Persaud · Johns Hopkins University · UM1 · FY2022 · AI
TRANSITION TO LOCAL OWNERSHIP AND INTEGRATION OF HIV PROGRAMS IN PRIMARY HEALTH C
$6,517,541Nzali Genevieve Kancheya · Centre For Infectious Disease Research · U2G · FY2012 · GH
DARE: Delaney AIDS Research Enterprise to find a cure.
$6,511,956Steven Grant Deeks · University Of California, San Francisco · U19 · FY2012 · AI
NorthStar Node of the Clinical Trials Network
$6,507,913Gavin Bart · Hennepin Healthcare Research Institute · UG1 · FY2022 · DA
GH16-002, Botswana: Impact Evaluation of Combination HIV Prevention Interventions
$6,503,896Myron E Essex · Harvard School Of Public Health · U2G · FY2017 · GH
The DC Cohort: A Longitudinal Population-Based Cohort Study of People Living with HIV in Washington, DC
$6,502,401Amanda Derryck Castel · George Washington University · R24 · FY2025 · AI
NIAID Regional Prospective Observational Research in Tuberculosis (RePORT) and Hepatitis Diagnostics
$6,500,000National Institute Of Allergy And Infectious Diseases · Y01 · FY2023 · AI